A Validated Clinical Risk Prediction Model for Lung Cancer in Smokers of All Ages and Exposure Types: A HUNT StudyMaria Markaki, Oluf Dimitri Røe, Ioannis Tsamardinos et al.|EBioMedicine|2018Cited by 72
‘Reduced’ HUNT model outperforms NLST and NELSON study criteria in predicting lung cancer in the Danish screening trialOluf Dimitri Røe, Haseem Ashraf, Maria Markaki et al.|BMJ Open Respiratory Research|2019Cited by 15
Increased levels of <scp>microRNA</scp>‐320 in blood serum and plasma is associated with imminent and advanced lung cancerTherese Haugdahl Nøst, Pål Sætrom, Torkjel M. Sandanger et al.|Molecular Oncology|2022Cited by 9
Improving Lung Cancer Screening Selection: The HUNT Lung Cancer Risk Model for Ever-Smokers Versus the NELSON and 2021 United States Preventive Services Task Force Criteria in the Cohort of Norway: A Population-Based Prospective StudyOlav Toai Duc Nguyen, Oluf Dimitri Røe, Ioannis Fotopoulos et al.|JTO Clinical and Research Reports|2024Cited by 6
The HUNT lung-SNP model: genetic variants plus clinical variables improve lung cancer risk assessment over clinical modelsOlav Toai Duc Nguyen, Oluf Dimitri Røe, Ioannis Fotopoulos et al.|Journal of Cancer Research and Clinical Oncology|2024Cited by 1